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Abstract: 
Orally fast dissolving films (OFDFs) have been introduced in the market recently as they provide convenience and 
ease of use over other dosage forms such as orally disintegrating tablets. This technology evolved over the past few 
years from the confection and oral care markets in the form of breath strips and became a novel and widely 
accepted form by consumers, so OFDFs are gaining the interest of large number of pharmaceutical industries. 
Orally fast dissolving film is the type of drug delivery system which when placed in the oral cavity, disintegrate or 
dissolve within few seconds without the intake of water. OFDFs are very similar to postage stamp in their shape, 
size and thickness. These films have a potential to deliver the drug systemically through intragastric, sublingual or 
buccal route of administration and also has been used for local action. This type of technology offer a convenient 
way of dosing medication, not to special population groups like pediatric, geriatric, bedridden patients, mentally ill 
patients, but also to the general population. The present review provides an account of various formulation 
considerations, method of preparation and quality control of the OFDFs.  
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Among the different routes, the most agreeable route 
for the patients is oral route. Most of the 
pharmaceutical companies have directed their 
research activity in developing viable dosage 
alternatives from oral route for pediatrics, geriatric, 
noncompliant or nauseous patients. Research in the 
oral drug delivery segment has led to evolution of 
dosage forms from simple conventional 
tablets/capsules to modified release tablets/capsules 
to oral disintegrating tablet to wafer to the recent 
development of fast dissolving oral films. Fast 
dissolving oral film, a novel drug delivery system for 
the oral delivery of the drugs is an ultra thin film 
prepared using hydrophilic polymers that rapidly 
dissolves on the top or the floor of the tongue or 
buccal cavity. It is an ultrathin strip (50- 150 microns 
thick) of postage stamp size with an active agent and 
other excipients developed on the basis of 
transdermal patch technology[1]. These evolved from 
the confectionery and oral care markets over past 
decade in the form of breath strips and became a 
novel and widely accepted dosage form by 
consumers for delivering vitamins and personal care 
products. These fast dissolving oral films have 
persistent to extend in sales and launched as patient 
compliant and convenient products effectively 
addressing issues for pharmaceuticals as well as 
nutraceuticals that have been traditionally 
administered as oral solid dosages. The delivery 
system consists of a very thin oral strip, which is 
simply placed on the patient’s tongue or any oral 
mucosal tissue, instantly wet by saliva the film 
rapidly hydrates and adheres onto the site of 
application [2]. It then rapidly disintegrates in a 
matter of seconds and dissolves to release medication 
for oromucosal absorption. Today, fast dissolving 
oral films are a well proven and world wide accepted 
technology for the systemic delivery of active 
pharmaceutical ingredients (APIs). 
Orally fast-dissolving film is new drug delivery 
system for the oral delivery of the drugs. It was 
developed on the basis of technology of the 
transdermal patch. The delivery system consists of a 
very thin oral strip, which is simply placed on the 
patient’s tongue or any oral mucosal tissue, instantly 
wet by saliva the film rapidly hydrates and adheres 
onto the site of application. It then rapidly 
disintegrates and dissolves to release the medication 
for oromucosal and intragastric absorption. 
Technology Catalysts forecasts the market for drug 
products in oral thin film formulations was valued of 
$500 million in 2007 and could reach $2 billion in 
2012. Based on upward global growth trends of the 
past decade, the fast dissolving dosage market could 
produce revenues of $13 billion by 2015  
 
Fig 1: oral thin film 
Special features of mouth dissolving films 
 Thin elegant film 
 Available in various size and shapes 
 Unobstructive 
 Excellent mucoadhesion 
 Fast disintegration 
 Rapid release 
ADVANTAGES  
Fast dissolving oral films being an advanced 
evolution of fast dissolving drug delivery systems 
have some outstanding advantages over conventional 
dosage forms and orally disintegrating tablets. They 
are: 
 Improved patient compliance.   
 As fast dissolving thin oral films are 
flexible, they are easy to carry, store and 
handle, which is not the case with orally 
disintegrating tablets (fragile and brittle) 
 Precision in the administered dose is ensured 
from each of the strips as compared to drops 
or syrup formulations.   
 Water is not needed for administering, so 
problem encountered in swallowing of 
tablets or capsules can be evaded.   
 Patients suffering from repeated emesis, 
dysphagia, and motion sickness prefer this 
dosage form as they are unable to swallow 
large quantity of water.   
 Availability of larger surface area leads to 
fast disintegration and dissolution in the oral 
cavity.   
 As the oral mucosa is being highly 
vascularized, drugs directly enter the 
systemic circulation without undergoing 
first‐pass hepatic metabolism.  
 This results in improved oral bioavailability 
of molecules.  These films can be 
manufactured through economically feasible 
nonsophisticated procedures and 
uncomplicated equipment. 
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The ideal characteristics of a drug to be selected 
 The drug should have pleasant taste.   
 The drug to be incorporated should have low 
dose upto 40 mg 
 The drugs with smaller and moderate 
molecular weight are preferable.   
 The drug should have good stability and 
solubility in water as well as in saliva.   
 It should be partially unionized at the pH of 
oral cavity.   
 It should have the ability to permeate oral 
mucosal tissue. 
Disadvantages 
 High doses cannot be incorporated.   
 Dose uniformity is a technical challenge 
 Active pharmaceutical ingredient 
 Film forming polymers 
 Plasticizer 
 Sweetening agent 
 Saliva stimulating agent 
 Flavoring agent 
 Coloring agent 
FORMULATION INGREDIENTS  
Drug (1-25%)  
Several class of drugs can be formulated as mouth 
dissolving films including antiasthamatics 
(Salbutamol sulphate), antiulcer (Omeprazole), 
expectorants, antitussives, NSAID’S (Valdecoxib, 
Meloxicam)  . 
Water Soluble Polymers (40-50%)  
To obtain the desired film properties, polymers can 
be used alone or in combination. Generally water-
soluble polymers are used as film formers as they 
achieve rapid disintegration, good mouthfeel and 
mechanical properties to the films. The strength of 
the film depends on the type of polymer and the 
amount in the formulation. By increasing the 
molecular weight of polymer film bases, 
disintegration rate of the polymer decreases. 
Polymers frequently used as film formers are water 
soluble grades of cellulose ethers, polyvinyl alcohol, 
polysaccharides, polyvinylpyrrolidone K- 90, 
polyethylene glycols, pullulan, gelatin, 
carboxmethylcellulose cekol 30, hydroxy propyl 
methyl cellulose E-3 and K-3, methyl cellulose A- 3, 
A-6 and A-15, pectin, sodium alginate, 
hydroxypropylcellulose, maltodextrins and eudragit 
RD10 . 
Plasticizers (0-20%)  
Plasticizer enhances mechanical properties such as 
tensile strength and elongation to the film by 
reducing the glass transition temperature of the 
polymer. It also reduces brittleness of the strip as a 
result improves its flexibility. Choice of plasticizer 
depends upon type of solvent used and its 
compatibility with the polymer. Some of the 
commonly employed plasticizers are phthalate 
derivatives like dimethyl, diethyl and dibutyl 
phthalate, low molecular weight polyethylene 
glycols, castor oil, citrate derivatives like tributyl, 
triethyl, acetyl citrate, triacetin and glycerol. 
Improper use of plasticizer may lead to blooming, 
film cracking, splitting and peeling of the strip. 
Surfactants  
Surfactants are used as wetting or solublising or 
dispersing agent so that the film is getting dissolved 
within seconds and release active agent immediately. 
Commonly employed are polaxamer 407, 
bezathonium chloride, sodium lauryl sulfate, tweens, 
benzalkonium chloride, etc. Out of these most 
predominantly used surfactant is polaxamer 407.  
Sweetening agents  
Some of the commonly employed sweeteners are 
dextrose, sucrose, fructose, glucose, isomaltose, 
polyhydric alcohols (sorbitol, mannitol), etc. 
Artificial sweeteners like saccharin, cyclamate, 
aspartame (first generation) and acesulfame‐K, 
sucralose, alitame, neotame (second generation) can 
also be used.  
Saliva stimulating agents  
Saliva stimulating agents are used to increase the rate 
of production of saliva that would help in the faster 
disintegration of the rapid dissoving strip 
formulations. Examples of salivary stimulants are 
citric acid, malic acid, lactic acid, ascorbic acid and 
tartaric acid. Among these the most preferred one is 
citric acid.  
Flavouring agents  
The quantity of flavouring agent required to mask the 
taste depends on the flavour type and its strength. 
Commonly employed are fruity flavours (vanilla, 
cocoa, coffee, chocolate, citrus), flavour oils 
(peppermint oil, cinnamon oil, oil of nutmeg). 
Flavours can also be chosen from oleo resins, 
synthetic flavour oils and extract derived from 
various parts of the plants like fruits, flowers etc. 
Colouring agents  
Generally incorporated colouring agents are FD&C 
colours, natural colours, pigments such as titanium 
dioxide etc  . 
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MANUFACTURE PROCESS OF FILMS [3-8] 
One (or a combination) of the following processes 
may be used to manufacture the oral films: 
 Solvent casting  
 Hot-melt extrusion  
 Solid dispersion extrusion  
 Rolling method. 
 Semisolid casting  
 
Solvent Casting Technique 
 
The method of solvent casting technique involves 
preparation of the film base which involves the 
mixing of suitable film forming excipients along with 
drug in a suitable solvent or solvent system. Once the 
solution is prepared, the film casting process is 
performed wherein a film of desired thickness is 
casted onto a moving inert substrate, where suitable 
rollers are employed for guiding the solution onto the 
substrate. The clearance or tolerance between the 
roller and the substrate determines the required 
thickness of the film; this process is used in large 
scale production wherein glass or Teflon plates can 
be used as inert support material to cast a film at the 
laboratory scale. The formed strip is then subjected to 
drying process to remove the solvent. 
The selection of solvent essentially depends on the 
API to be incorporated into the film. The 
physicochemical properties of the API like heat 
sensitivity, shear sensitivity, the polymorphic form of 
the API employed, compatibility of the API with 
solvent and film based excipients are to be critically 
studied. The predominant factors to be considered are 
liquid rheology, desired mass to be casted and 
uniformity of drug content. Solvent systems used in 
the preparation of solution or suspension should be 
selected carefully and more preferably from ICH 
Class 3 solvent list. 
Heating processes can be used to assist the complete 
dissolution of materials. Mixing may cause formation 
of air bubbles and their entrapment during the 
solution preparation. Entrapped air tends to produce 
uneven films. Deaeration step is imperative to get a 
uniform film which may be achieved by vacuum 
assisted machines. Another important aspect is the 
moisture present in the solution. It is observed that 
moisture can cause changes in the mechanical 
properties of the films such as tensile strength, 
flexibility, folding endurance, Young's modulus, 
elongation etc. Hence care should be exercised by 
using suitable humidity controls in the manufacturing 
production area. The solution is subjected to 
continuous mixing process in order to keep the 
viscosity and concentration unchanged. The solution 
or suspension may be kept under controlled 
temperature condition to achieve the desired viscosity 
of the material. 
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Hot Extrusion Process 
Hot melt extrusion (HME) is commonly used to prepare granules, sustained-release tablets, and transdermal and 
transmucosal drug delivery systems. This technique involves shaping a polymer into a film via the heating process 
rather than through the traditional solvent casting method. In this process API and other ingredients are mixed in dry 
state which are subjected to heating process and then extruded out in molten state. These processes do not involve 
use of any solvents systems. The molten mass thus formed is used to cast the film. The films are further cooled and 
cut to the desired size. The main disadvantage of this process is high temperature used in the process might degrade 
thermolabile APIs. The critical step is the casting and the drying process. Optimization of speed of casting and 
drying time are important from the commercial scale output. Hot-melt extrusion include lower temperature and 
shorter residence time of the drug carrier mix (<2 minutes), absence of organic solvents, continuous operation 
possibility, minimum product wastage, good control of operating parameters, and possibility to scale up. Repka et al. 
prepared chlorpheniramine maleate (CPM) topical HPC films by hot melt extrusion technique using hydroxy propyl 
cellulose as polymer. 
 
Solid Dispersion Extrusion 
The term “solid dispersions” refers to the dispersion of one or more active ingredients in an inert carrier in a solid 
state in the presence of amorphous hydrophilic polymers and also using methods such as melt extrusion. This 
involves a drug which is first dissolved in a suitable liquid solvent and then this solution is incorporated into the 
melt of suitable polymer, obtainable below 70º C without removing the liquid solvent. The selected solvent or 









Fig 4: Solid dispersion Extrusion 
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Fig 5: Rolling method 
 
Rolling Method 
In this method, the film is prepared by pre-mixing of 
an active ingredients and excipients followed by 
subsequent addition of the solvent. The pre-mix or 
master batch which includes the film- forming 
polymer, polar solvent, and any other additives 
except a drug active is added to the master batch feed 
tank .Then a pre-determined amount of the master 
batch is controllably fed via a first metering pump 
and control valve to either or both of the first and 
second mixers. The required amount of the drug is 
added to the desired mixer through an opening in 
each of the mixers. After the drug has been blended 
with the master batch pre- mix for a sufficient time to 
provide a uniform matrix, a specific amount of the 
uniform matrix is then fed to the pan through the 
second metering pumps. The film is finally formed 
on the inert substrate and carried away via the 
support roller. Thus the wet film is then dried using 
controlled bottom drying, desirably in the absence of 
external air currents or heat on the top (exposed) 
surface of the film. 
 
Semisolid casting  
In semisolid casting method firstly a solution of 
watersoluble film forming polymer is prepared. The 
resulting solution is added to a solution of acid 
insoluble polymer (e.g. cellulose acetate phthalate, 
cellulose acetate butyrate), which was prepared in 
ammonium or sodium hydroxide. Then appropriate 
amount of plasticizer is added so that a gel mass is 
obtained. Finally the gel mass is casted in to the films 
or ribbons using heat controlled drums. The thickness 
of the film is about 0.015-0.05 inches.  
 
Storage and Packaging 
 Owing to the preparation of film considered to be 
quite interesting, even the storage of the film gained 
the sense of attention in order to dispense in such a 
manner that it reaches to the expectations of both 
storage properties required to be maintained along 
with easy packaging and also easy withdrawal of the 
drug delivery system by the patient. 
 
After sizing of the films into desired dimensions they 
are to be stored in the controlled conditions at 
250C/65% RH and/or at 400C/75% RH in a stability 
chamber for about 12 months as mentioned in the 
ICH guidelines Q1A. In order to prevent from any 
contamination the films are clamped to the slide 
frames to maintain the films from contacting from 
any surfaces and also from each other and this also 
helps in saving the space34.There are different 
varieties of packaging processes available for fast 
dissolving films. Single packaging is quite widely 
used in the case of the pharmaceutical products 
which generally involve an aluminium pouch used 
for the packaging format. 
 
APR-Labtec has developed the special designed 
packaging system called Rapid card, a proprietary 
and patented packaging system for the Rapid films. 
The rapid card resembles that of a credit card that can 
hold three rapid films on either side. They are stacked 
upon each other and can be easily taken out 
individually just by sliding with a single finger. 
Further these quick dissolving strips or films are 
available in a number of flavors which are packed 
into a small disposable plastic or metal packlet with a 
proper hermetic sealing containing 20 to 32 strips per 
pack. The non-adhering films are stacked upon each 
other and a single strip can be easily dispensed by 
placing a finger on the strip and moving it forward 
with a sliding motion, thus dispensing the strip out of 
the packlet. 
 
APPLICATIONS OF FILM DELIVERY 
SYSTEM [9-19] 
Taste Masking: Oral film systems dissolve or 
disintegrate in patient’s mouth, thus releasing the 
active ingredients on contact with the taste buds and 
hence, taste masking of the drugs becomes critical to 
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make it patient compliant. An important aspect of 
thin oral film technology is the masking of the bitter 
and poor taste of drug formulations. One method of 
taste-masking is encapsulation, the coating of drug 
particles with polymers sufficient to mask the taste of 
the drug particle while maintaining the ability to 
release the drug for absorption. 
 
Orally Disintegrating Films: Oral thin film 
disintegration property is based on the polymers 
used. The film disintegrates rapidly within seconds in 
contact with water or saliva, releases the drug in the 
mouth and promotes gastrointestinal absorption. 
 
Vaccination: Oral thin film can be used to deliver 
vaccines by quickly dissolving in mouth and in 
saliva. Rotavirus vaccine is prepared in US by Johns 
Hopkins University in 2006. Rotavirus vaccine is a 
room temperature stable quick-dissolving oral thin 
film delivery system for vaccines that will make 
vaccinations almost as simple as breath freshners. 
This delivery system exhibits many advantages not 
available in current products which include improved 
patient compliance, improved bioavailability, 
reduction in the costs associated with storage, 
distribution, handling and administration. 
Sustained Release Film: Sustained release oral film 
is applicable in hospital preparations and drug 
carriers using polymer Chitin and chitosan 
derivatives as excipients and drug carriers in the 
pharmaceutical field. Chitosan is used as excipients 
in oral dosage form. Films prepared using chitin or 
chitosan have been developed as wound dressings, 
oral mucoadhesive and water-resisting adhesive by 




 Dryness/tack test 
 Tensile strength 
 Percent elongation 
 Young’s modulus 
 Tear resistance 
 Folding endurance 
Organoleptic test 
Swelling test 





In-vitro Dissolution test 
 
Thickness  
As the thickness of film is directly concern with drug 
content uniformity so it is necessary to ascertain 
uniformity in the thickness of the film. It can be 
measured by micrometer screw gauge or calibrated 
digital Vernier Calipers at different strategic 
locations. 
Dryness test/tack tests  
About eight stages of film drying process have been 
identified and they are set‐to‐touch, dust‐free, 
tack‐free (surface dry), Dry‐to touch, dry‐hard, 
dry‐through (dry‐to‐handle), dry‐to‐recoat and dry 
print‐free. Although these tests are primarily used for 
paint films most of the studies can be adapted 
intricately to evaluate pharmaceutical OFDF. The 
details of evaluation of these parameters can be 
checked elsewhere and are beyond the scope of this 
review. Tack is the tenacity with which the strip 
adheres to an accessory (a piece of paper) that has 
been pressed into contact with the strip. Instruments 
are also available for this study.  
Tensile strength  
Tensile strength is the maximum stress applied to a 
point at which the strip specimen breaks. It is 
calculated by the applied load at rupture divided by 
the cross‐sectional area of the strip. 
Percent elongation  
When stress is applied, a strip sample stretches and 
this is referred to as strain. Strain is basically the 
deformation of strip divided by original dimension of 
the sample. Generally elongation of strip increases as 
the plasticizer content increases 
Young's modulus  
Young's modulus or elastic modulus is the measure 
of stiffness of strip. It is represented as the ratio of 
applied stress over strain in the region of elastic 
deformation  
Hard and brittle strips demonstrate a high tensile 
strength and Young's modulus with small elongation 
Tear resistance  
Tear resistance of plastic film or sheeting is a 
complex function of its ultimate resistance to rupture. 
Basically very low rate of loading 51 mm (2 in)/min 
is employed and is designed to measure the force to 
initiate tearing. The maximum stress or force (that is 
generally found near the onset of tearing) required to 
tear the specimen is recorded as the tear resistance 
value in Newtons (or pounds‐force).  
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Folding endurance  
Folding endurance is determined by repeated folding 
of the strip at the same place till the strip breaks. The 
number of times the film is folded without breaking 
is computed as the folding endurance value. 
Organoleptic evaluation  
For evaluation of psychophysical evaluation of the 
product, special controlled human taste panels are 
used. In-vitro methods of utilizing taste sensors, 
specially designed apparatus and drug release by 
modified pharmacopoeial methods are being used for 
this purpose. These in-vitro taste assessment 
apparatus and methodologies are well suited for 
high‐throughput taste screening of oral 
pharmaceutical formulations.  
Surface pH of film  
Surface pH of the films was determined by placing 
the film on the surface of 1.5% w/v agar gel followed 
by placing pH paper (pH range 1-11) on films. The 
change in the colour of pH paper was observed and 
reported.  
Swelling property  
Film swelling studies is conducted using simulated 
saliva solution. Each film sample is weighed and 
placed in a preweighed stainless steel wire mesh. The 
mesh containing film sample is submerged into 15ml 
medium in a plastic container. Increase in the weight 
of the film was determined at preset time interval 
until a constant weight was observed.  
The degree of swelling was calculated using 
parameters  
α = wt - wo/wo  
wt is weight of film at time t,  
and wo is weight of film at time zero.  
Transparency  
The transparency of the films can be determined 
using a simple UV spectrophotometer. Cut the film 
samples into rectangles and placed on the internal 
side of thespectrophotometer cell. The determine 
transmittance of films at 600 nm. The transparency of 
the films was calculated as follows:  
Transparency = (logT600)/b = - €c  
Where T600 is the transmittance at 600 nm and b is 
the film thickness (mm) and c is concentration.  
Assay/ Content uniformity  
This is determined by any standard assay method 
described for the particular API in any of the standard 
pharmacopoeia. Content uniformity is determined by 
estimating the API content in individual strip. Limit 
of content uniformity is 85–115 percent.  
Disintegration time  
Disintegration of orally fast dissolving films requires 
USP disintegration apparatus. The disintegration time 
limit of 30 seconds or less for orally disintegrating 
tablets described in CDER guidance can be applied to 
fast dissolving oral strips. Disintegration time will 
vary depending on the formulation but typically the 
disintegration range from 5 to 30 seconds. Although, 
no official guidance is available for oral fast 
disintegrating films strips.  
Dissolution test  
Dissolution testing can be performed using the 
standard basket or paddle apparatus described in any 
of the pharmacopoeia. The dissolution medium will 
essentially be selected as per the sink conditions and 
highest dose of the API. Many times the dissolution 
test can be difficult due to tendency of the strip to 
float onto the dissolution medium when the paddle 
apparatus is employed. 
CONCLUSION:  
The growing success and popularity of fast dissolving 
oral film recently in global market is evidence to the 
need for effective taste masked, "without water" 
pharmaceutical formulations. Fast dissolving oral 
films being a natural evolution of fast dissolving drug 
delivery systems have prominent advantages over 
conventional dosage forms and orally disintegrating 
tablets. Due to their immense importance during the 
emergency cases such as allergic reactions and high 
patient compliance, fast dissolving oral films have 
evolved as consumer friendly dosage forms. So many 
of the pharmaceutical companies are launching this 
technology as these films can be manufactured 
through non-sophisticated, uncomplicated equipment 
and procedures. Due to these, fast dissolving films 
have economically feasible developmental futuristic 
opportunities. 
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